BioCentury | Oct 9, 2020
Finance
Kronos’ post-IPO gains build on $1B+ postmoney valuation
...gains were Shattuck Labs Inc. (NASDAQ:STTK) and Spruce Biosciences Inc....
...CD172a; SHPS-1) - Signal regulatory protein alpha Paul Bonanos Spruce Biosciences Inc. Shattuck...
...CD172a; SHPS-1) - Signal regulatory protein alpha Paul Bonanos Spruce Biosciences Inc. Shattuck...